Chris DeRenzo
St. Jude Children's Research Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Chris DeRenzo as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:52 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT04897321 · B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)St. Jude Children's Research Hospital · recruiting · Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:52 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Enhancing B7-H3-CAR T cell therapy for pediatric solid tumorsR01CA262589 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · fiscal years 2022 to 2025 · $754,519 awarded in 2025Same name and institution; not confirmed by an ID
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in atypical teratoid rhabdoid tumour (at/rt).